These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 1100542

  • 1. Tritiated digoxin: studies in renal disease in human subjects.
    Doherty JE, Bissett JK, Kane JJ, de Soyza N, Murphy ML, Flanigan WJ, Dalrymple GV.
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):89-95. PubMed ID: 1100542
    [Abstract] [Full Text] [Related]

  • 2. Digitalis therapy in renal failure with special regard to digitoxin.
    Vöhringer HF, Rietbrock N.
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):175-84. PubMed ID: 7021432
    [Abstract] [Full Text] [Related]

  • 3. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S, Orlando R, Bertoli M, Pegoraro P, Palatini P.
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [Abstract] [Full Text] [Related]

  • 4. Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients.
    Vasdev S, Johnson E, Longerich L, Prabhakaran VM, Gault MH.
    Clin Nephrol; 1987 Apr; 27(4):169-74. PubMed ID: 3034459
    [Abstract] [Full Text] [Related]

  • 5. Improved urea clearance raises the BUN in continuous peritoneal dialysis.
    Baltzan MA, Shoker AA, Baltzan RB, Pylypchuk GB.
    Clin Nephrol; 1996 Mar; 45(3):183-7. PubMed ID: 8706360
    [Abstract] [Full Text] [Related]

  • 6. Studies with tritiated digoxin in anephric human subjects.
    Doherty JE, Flanigan WJ, Perkins WH, Ackerman GL.
    Circulation; 1967 Feb; 35(2):298-303. PubMed ID: 6022799
    [No Abstract] [Full Text] [Related]

  • 7. Interpretation of serum digoxin values in renal failure.
    Gault H, Vasdev S, Vlasses P, Longerich L, Dawe M.
    Clin Pharmacol Ther; 1986 May; 39(5):530-6. PubMed ID: 3698461
    [Abstract] [Full Text] [Related]

  • 8. Effects of renal failure on blood levels of cimetidine.
    Ma KW, Brown DC, Masler DS, Silvis SE.
    Gastroenterology; 1978 Feb; 74(2 Pt 2):473-7. PubMed ID: 620915
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 11. Multiple-dose kinetics of digoxin in neonates.
    Collins-Nakai RL, Schiff D, Ng PK.
    Pediatr Pharmacol (New York); 1985 Nov; 5(2):117-22. PubMed ID: 4047750
    [Abstract] [Full Text] [Related]

  • 12. Tritiated digoxin. XVII. Excretion and turnover times in normal donors before and after nephrectomy and in the paired recipient of the kidney after transplantation.
    Doherty JE, Flanigan WJ, Dalrymple GV.
    Am J Cardiol; 1972 Apr; 29(4):470-4. PubMed ID: 4552737
    [No Abstract] [Full Text] [Related]

  • 13. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA, Hak LJ, Coakley DF, Falk RJ, Wagner BE, Raasch RH, van der Horst CM, Kaul S, Barbhaiya RH, Dukes GE.
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [Abstract] [Full Text] [Related]

  • 14. [Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)].
    Ohnhaus EE, Spring P, Dettli L.
    Dtsch Med Wochenschr; 1974 Sep 13; 99(37):1797-803. PubMed ID: 4457307
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease.
    Teichert J, Tuemmers T, Achenbach H, Preiss C, Hermann R, Ruus P, Preiss R.
    J Clin Pharmacol; 2005 Mar 13; 45(3):313-28. PubMed ID: 15703366
    [Abstract] [Full Text] [Related]

  • 16. Circulating type VI collagen and undulin, in patients with kidney diseases, after kidney transplantation and on hemodialysis.
    Marder K, Keller F, Schuppan D.
    Clin Nephrol; 1995 Sep 13; 44(3):178-84. PubMed ID: 8556834
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic aspects of digoxin in patients with terminal renal failure. IV. Clinical implications of own observations with a recent review of literature.
    van der Vijgh WJ, Oe PL.
    Int J Clin Pharmacol Biopharm; 1978 Nov 13; 16(11):540-6. PubMed ID: 730421
    [Abstract] [Full Text] [Related]

  • 18. [Biological availability of diagoxin in patients with or without gastric resection (Billroth II) (author's transl)].
    Ochs H, Bodem G, Kodrat G, Savic B, Baur MP.
    Dtsch Med Wochenschr; 1975 Nov 21; 100(47):2430-4. PubMed ID: 810339
    [Abstract] [Full Text] [Related]

  • 19. Renal clearance of digoxin in young infants.
    Gorodischer R, Jusko WJ, Yaffe SJ.
    Res Commun Chem Pathol Pharmacol; 1977 Feb 21; 16(2):363-74. PubMed ID: 847290
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic aspects of digoxin in patients with terminal renal failure. I. Off dialysis.
    van der Vijgh WJ.
    Int J Clin Pharmacol Biopharm; 1977 Jun 21; 15(6):249-54. PubMed ID: 881276
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.